Angion biomedica corp.

Major-Pharmaceuticals

ANGN


51 Charles Lindbergh Boulevard
Uniondale , NY 11553

Executive/
Director

Price

  • Last Close
  • $ 1
    $ +0.02 2.04 %
    Jun 1, 2023
  • 52-Week High/Low
  • $0 - $0
  • YTD
  • 0%

  • Trading Volume
  • 224,845
  • Market Cap Full
  • $ 8.4M
  • Shares Outstanding
  • 8.4M
    Nov 7, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - - - - - - -26.2% -28.6% -
Q2 - - - - - - -27.1% -46.4% 72.4% -
Q3 - - - - - - -25% -19.3% - -
Q4 - - - - - - -70.5% -11.7% - -
J F M A M J J A S O N D
2024 - - - - - - - - - - - -
2023 -11.3% -11.1% -9.4% 31% 29% 2% - - - - - -
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%0%0%0%0%0%-72%23%0%

Earnings

2020 2021 2022
Q1 - -1.56 -0.48
Q2 - -0.58 -0.3
Q3 - -0.53 -0.3
Q4 - 0.74 -0.21
A -5.4 -1.9 -1.3

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2021 2022 2023
Mar - 30 30.1
Jun 29.7 30 30.1
Sep 29.8 30.1 8.4
Dec 30 30.1 8.4

Financial Ratios

20202019
Asset Management
Inventory / Stock Turnover - -
Fixed Asset Turnover 0.6 0.3
Total Asset Turnover 0.1 0.1
Leverage
Debt Ratio - -
Debt – Equity Ratio - -
Interest Coverage -2.2 -18.7
Equity multiplier -0.1 -0.3